现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
25期
2760-2763
,共4页
陈欣华%孙琪%李亮%梁建英%孟文格%刘金波
陳訢華%孫琪%李亮%樑建英%孟文格%劉金波
진흔화%손기%리량%량건영%맹문격%류금파
缺血性心肌病%心力衰竭%神经内分泌因子%左室重构%芪苈强心胶囊
缺血性心肌病%心力衰竭%神經內分泌因子%左室重構%芪藶彊心膠囊
결혈성심기병%심력쇠갈%신경내분비인자%좌실중구%기력강심효낭
ischemic heart disease%heart failure%neurohumoral factors%left ventricular remodeling%Qiliqiangxin cap-sules
目的:观察芪苈强心胶囊对缺血性心肌病心力衰竭患者神经内分泌因子、左室重构及心功能的影响。方法将60例缺血性心肌病心力衰竭患者随机分为治疗组与对照组各30例,对照组予以常规治疗,治疗组在常规治疗基础上加用芪苈强心胶囊治疗。观察2组患者治疗前后N末端脑钠肽原( Nt-proBNP)、心肌肌钙蛋白I(cTnI)、超敏C反应蛋白(hs-CRP)及左室舒张末内径( LVEDD)、左室射血分数( LVEF)的变化情况。结果2组治疗后LVEDD、NT-proBNP、cTnI、hs-CRP水平均明显降低,LVEF水平明显增加,而且治疗组治疗后6个月与对照组同期比较各指标改善更明显(P均<0.05)。结论在心力衰竭常规治疗的基础之上加用中成药芪苈强心胶囊能够降低NT-proBNP、cTnI、hs-CRP的水平,逆转左室重构,改善心功能。
目的:觀察芪藶彊心膠囊對缺血性心肌病心力衰竭患者神經內分泌因子、左室重構及心功能的影響。方法將60例缺血性心肌病心力衰竭患者隨機分為治療組與對照組各30例,對照組予以常規治療,治療組在常規治療基礎上加用芪藶彊心膠囊治療。觀察2組患者治療前後N末耑腦鈉肽原( Nt-proBNP)、心肌肌鈣蛋白I(cTnI)、超敏C反應蛋白(hs-CRP)及左室舒張末內徑( LVEDD)、左室射血分數( LVEF)的變化情況。結果2組治療後LVEDD、NT-proBNP、cTnI、hs-CRP水平均明顯降低,LVEF水平明顯增加,而且治療組治療後6箇月與對照組同期比較各指標改善更明顯(P均<0.05)。結論在心力衰竭常規治療的基礎之上加用中成藥芪藶彊心膠囊能夠降低NT-proBNP、cTnI、hs-CRP的水平,逆轉左室重構,改善心功能。
목적:관찰기력강심효낭대결혈성심기병심력쇠갈환자신경내분비인자、좌실중구급심공능적영향。방법장60례결혈성심기병심력쇠갈환자수궤분위치료조여대조조각30례,대조조여이상규치료,치료조재상규치료기출상가용기력강심효낭치료。관찰2조환자치료전후N말단뇌납태원( Nt-proBNP)、심기기개단백I(cTnI)、초민C반응단백(hs-CRP)급좌실서장말내경( LVEDD)、좌실사혈분수( LVEF)적변화정황。결과2조치료후LVEDD、NT-proBNP、cTnI、hs-CRP수평균명현강저,LVEF수평명현증가,이차치료조치료후6개월여대조조동기비교각지표개선경명현(P균<0.05)。결론재심력쇠갈상규치료적기출지상가용중성약기력강심효낭능구강저NT-proBNP、cTnI、hs-CRP적수평,역전좌실중구,개선심공능。
O bjective It is to investigate the effect of Qiliqiangxin capsules on neurohumoral factors , left ventricular re-modeling and heart function in the patients with ischemic heart disease with chronic heart fai 1ure.Methods 60 patients with chronic heart fai1ure were randomly divided into two groups ,one was control group treated by routine treatment ,another was treatment group treated with Qiliqiangxin capsules on the basis of above regular treatment .The changes of clinical symptoms , left ventricular end diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF),plasma levels of NT Pro-BNP, cT-nI and hs-CRP were observed in both groups before and after treatment .Results After therapy,the levels of LVEDD,NT -proBNP, cTnI, hs-CRP were lower, while the level of LVEF was higher than those before treatment in both groups , and the improvements of these indexes were more obviously in treatment group than those in control group after 6 months'treatment. Conclusion The treatment with Qiliqiangxin capsules combined with routine treatment for heart failure can decrease the levels of NT-proBNP ,cTnI and hs-CRP, improve heart function and reverse left ventricular remodeling .